Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOPAN: Folfirinox vs Gemcitabine in Locally Advanced Pancreatic Carcinoma
NCT02539537Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 2015
- Primary completion
- Feb 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid in pancreatic carcinoma, sponsored by Unicancer. Started Oct 2015; status: completed.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acid
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT02539537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539537.